Roche s Elecsys NfL test is intended to be used as an aid in detection of disease activity in adults with relapsing-remitting multiple sclerosis or secondary progressive multiple sclerosis.
An expert panel has proposed a new framework for the diagnosis and treatment of multiple sclerosis to replace the current subtype classifications, based on disease progression.
New recommendations help clinicians communicate technical information to help patients with multiple sclerosis achieve better understanding and self-care.
A test that measures kappa in cerebrospinal fluid is faster, easier, and less costly for diagnosing multiple sclerosis than a more commonly used test, new research suggests.
A new indirect comparison of three new FDA-approved treatment options for aquaporin4+ neuromyelitis optica has suggested that eculizumab is the most effective. But many limitations have been raised.